Med-Design Corp. (The) (MEDC)

Med-Design Corp. (The) (MEDC) — VMCI valuation read

Headline read on MEDC: VMCI of 26/100 versus a Healthcare sector median of 50. The 24-point below-median position is what makes Med-Design Corp. (The) a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on MEDC: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on MEDC: value (MEDC trades at 15.0x earnings, 17% below the Healthcare median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 1.4x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

MEDC rose 2.1% over the trailing 7 days, with a +4.4% read on a 30-day basis.